Fmoc-L-Alanine

Fmoc-L-Alanine is an Fmoc-protected L-alanine derivative in which the α-amino group is carbamate-protected by the 9H-fluorenylmethoxycarbonyl (Fmoc) group, while the carboxyl functionality is present as a free acid suitable for peptide coupling chemistry. The stereogenic center corresponds to L-alanine, providing defined chiral information for stereochemically controlled peptide bond formation and downstream structure-function studies. The Fmoc group introduces an aromatic, base-labile protecting handle that can be removed under standard peptide-synthesis deprotection conditions to regenerate the reactive amino terminus. The combination of an Fmoc-protected amine and a carboxylic acid enables predictable reactivity patterns for amide formation, derivative construction, and incorporation into larger peptide and peptidomimetic scaffolds.

1. Fmoc Peptide Synthesis

Fmoc-L-Alanine is used in solid-phase and solution-phase peptide synthesis workflows where Fmoc protection supports stepwise N-terminal deprotection and coupling. The L-alanine α-amino carbamate and free carboxylic acid enable formation of amide bonds with activated carboxyl partners, while the defined L-configuration maintains stereochemical fidelity in the growing peptide chain. The Fmoc group's base-labile behavior supports controlled exposure of the amine for sequential elongation, including preparation of Ala-rich sequences and termini for fragment assembly. The resulting alanine-containing peptides and peptide intermediates serve as research-grade building blocks for biochemical assays, protein engineering constructs, and synthetic library generation.

2. Protected Amino Acid Chemistry

Fmoc-L-Alanine is applied as an N-protected amino acid intermediate for amino acid derivatization strategies that require orthogonal handling of the amine functionality. The Fmoc carbamate can be retained during selective transformations on the carboxyl group or used as a stable protecting group during multi-step synthesis that culminates in peptide-ready amide formation. The presence of a stereogenic L-center supports stereoselective incorporation into peptides and chiral intermediate preparation for chiral building block development. Downstream utility includes conversion into activated derivatives for coupling, preparation of alanine analogs for SAR studies, and construction of defined peptide fragments used in chemical biology research.

3. SAR Studies And Molecular Design

Fmoc-L-Alanine is employed in medicinal chemistry-oriented peptide and peptidomimetic design efforts where alanine substitutions probe backbone sterics, conformational preferences, and binding-site tolerance. The small side chain of alanine, combined with the Fmoc-protected N-terminus, facilitates systematic replacement strategies in peptide scaffolds while maintaining consistent coupling chemistry across analog series. The stereochemically defined residue supports interpretation of structure-activity relationship studies where stereochemical scrambling can otherwise confound SAR conclusions. The compound also functions as a practical building block for generating analog panels, enabling downstream characterization workflows such as binding assays, stability comparisons, and analytical method development for peptide analogs.

4. Bioconjugation Linker Building

Fmoc-L-Alanine is suitable for constructing peptide-based linkers and conjugation handles that rely on controlled N-protection and predictable amide coupling chemistry. The Fmoc-protected amine can be deprotected to generate a free amino terminus that can participate in subsequent functionalization steps, including attachment of reporter groups, affinity tags, or polymerizable moieties through amide or carbamate-forming strategies. The carboxyl group provides a handle for further activation and coupling to biomolecule-derived fragments, supporting preparation of defined conjugates with alanine-containing spacer segments. The resulting conjugation intermediates can be used for chemical biology experiments, biomolecule labeling workflows, and analytical standard preparation where reproducible linker architecture matters.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-Alanine is utilized in pharmaceutical manufacturing and process chemistry contexts as a protected amino acid feedstock for producing peptide intermediates and process-relevant fragments. The Fmoc protection strategy supports controlled handling of the amine during synthetic sequence design, while the L-alanine stereochemistry aligns with the stereochemical requirements of peptide-based intermediates. The compound's compatibility with standard peptide coupling activation chemistries enables scalable route design for fragment assembly, purification-friendly intermediate formation, and subsequent conversion into larger peptide structures. Downstream manufacturing utility includes preparation of defined alanine-containing segments used in the synthesis of peptide-active ingredients, peptide excipients, or peptide-based research materials requiring consistent stereochemical composition.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. Application of human liver organoids as a patient-derived primary model for HBV infection and related hepatocellular carcinoma

3. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

4. TMEM16F and dynamins control expansive plasma membrane reservoirs

5. Crystal Structure of BamB from Pseudomonas aeruginosa and Functional Evaluation of Its Conserved Structural Features